Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.499 0.0  0.2%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.90m
Enterprise Value £6.24m
Revenue £n/a
Position in Universe 1690th / 1874

BRIEF-Cereno Scientific Submits Application For Start Of Clinical Phase II Study To Bulgarian Authorities

Fri 31st May, 2019 10:39am
May 31 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC SUBMITS APPLICATION FOR THE START OF
CLINICAL
PHASE II STUDY TO BULGARIAN AUTHORITIES
    * AIM OF PHASE II STUDY IS TO SHOW DRUG CANDIDATE CS1'S
PREVENTIVE
EFFECT AGAINST FORMATION OF BLOOD CLOTS AFTER SURGERY
    * STUDY WILL BE CONDUCTED AT APPROXIMATELY 30 CLINICS IN
RUSSIA
AND BULGARIA
    * WE LOOK FORWARD TO OBTAINING APPROVAL OF SAID AUTHORITIES
DURING
FALL THIS YEAR AND SUBSEQUENTLY TO INITIATE STUDY, WHICH IS
EXPECTED TO TAKE PLACE DURING FIRST HALF OF 2020 - CEO

Source text for Eikon:  ID:nWkr1vjLXQ 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.